Name: | Maria do Rosário Rodrigues de Almeida Martins |
Sigla: | MRRAM |
Estado: | Active |
R-000-B8E | |
0000-0001-9289-3835 | |
D91F-F83F-A3FD | |
K-3938-2013 | |
57190193603 |
Extensão Telefónica: | 5140 |
|
Cargo | Data de Início |
---|---|
Member of the Program Follow-up Committee - Mestrado em Bioquímica | 2023-10-17 |
Rosário Almeida is Associate Professor at the Institute of Biomedical Sciences of Abel Salazar (ICBAS) at the University of Porto (UP) since 2006. She graduated in Biochemistry at UP in 1986 and joined ICBAS as a Trainee Assistant in 1987. She got a certificate of ce of Pedagogical Aptitude and Scientific Capacity in 1991 and received a PhD in Biomedical Sciences, Specialty in Biochemistry at ICBAS in 1995, under the supervision of Prof. Maria João Saraiva.
At ICBAS, she is a member of the Molecular Biology department and is responsible or co-responsible for curricular units (UCs) in the area of structural and metabolic biochemistry and, in particular, protein structure and function for the gradiuation courses and master courses of Biochemistry and Bioengineering. She also collaborates in teaching at other courses. She has been Director/Co-Director of the graduation course in Biochemistry from 2012 to 2021. She has also been Member of the Pedagogical Council and from 2010 to 2018 she has been Member of the ICBAS Representative Committee.
Her research focuses mainly on the study of transthyretin (TTR) amyloidosis having developed her doctoral project at the Paramyloidosis Study Center of the Hospital Geral de Santo António. She continued her scientific work at the Institute of Molecular and Cellular Biology (IBMC) and is currently a senior researcher in the Molecular Neurobiology Group at I3S – Institute for Research and Innovation in Health. The work she has developed aims to understand the molecular mechanisms and pathophysiology of the disease. In this sense, she has investigated the effect of natural and synthetic modulators, in vitro and in vivo in animal models, to contribute to the discovery of specific therapeutic approaches. Recently, she has been investigating the involvement of proteolysis in TTR aggregation and in its pathology, particularly associated with the cardiac and ocular forms of TTR amyloidosis.
Throughout her career she has participated in several competitive and non-competitive funded projects as a PI or as a researcher and has supervised more than 20 undergraduate students and several master's (6) and PhD students (6) and published more than 60 articles in international scientific journals (h-index=28).